{"id":"W4389850548","doi":"10.1016/j.jtocrr.2023.100621","title":"Adjuvant Osimertinib in Patients With Stage IB to IIIA EGFR Mutation-Positive NSCLC After Complete Tumor Resection: ADAURA China Subgroup Analysis","year":2023,"lang":"en","type":"article","venue":"JTO Clinical and Research Reports","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"AstraZeneca","keywords":"Osimertinib; Medicine; Oncology; Adjuvant; Internal medicine; Subgroup analysis; Stage (stratigraphy); Epidermal growth factor receptor; Meta-analysis; Biology; Cancer; Erlotinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002117203,0.001439382,0.002954444,0.001059704,0.0005123853,0.0009333423,0.0006429413,0.0007064171,0.001899181],"category_scores_gemma":[0.001031621,0.0004686929,0.006942628,0.001092168,0.0003300819,0.0003361508,0.0005789174,0.0006969373,0.0002319948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009799117,"about_ca_system_score_gemma":0.001788295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004490239,"about_ca_topic_score_gemma":0.01434745,"domain_scores_codex":[0.9988621,0.0003928173,0.0001449576,0.0002237713,0.0001704702,0.0002059096],"domain_scores_gemma":[0.9994751,0.00009002401,0.0001307737,0.0001165506,0.00007401982,0.0001135784],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.4170656,0.001553496,0.4245761,0.002489705,0.0832044,0.0009168014,0.000462161,0.002363608,0.01129074,0.0003578221,0.004697753,0.0510218],"study_design_scores_gemma":[0.1037654,0.02185687,0.7428524,0.0002987768,0.1131341,0.0005860458,0.0005897102,0.005092886,0.002258932,0.0007522258,0.008640246,0.0001724558],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849867,0.01004669,0.0005065248,0.0002849667,0.0001256142,0.0007738038,0.001929038,0.00001844631,0.001328278],"genre_scores_gemma":[0.9941313,0.001129722,0.0002974328,0.0003573335,0.0001141668,0.0006463344,0.00221717,0.000009843888,0.001096692],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004490239,"threshold_uncertainty_score":0.01119697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04608447736501201,"score_gpt":0.4356944729193147,"score_spread":0.3896099955543027,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}